You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

Article info

Article menu

Download PDFPDF

Extended report
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

Authors

  1. Harry K Genant, University of California, San Francisco, San Francisco, CA, USA; harry.genant{at}ucsf.edu
View Full Text

Citation

Genant HK, Peterfy CG, Westhovens R, et al
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
Annals of the Rheumatic Diseases 2008;67:1084-1089.

Publication history

  • Accepted November 17, 2007
  • First published December 17, 2007.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism